UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No.   *)

COLORADO MEDTECH, INC.
(Name of Issuer)

Common Stock
(Title of Class of Securities)

19652U 10 4
(CUSIP Number)

Peter E. Salas, General Partner of
Dolphin Offshore Partners, L.P.
c/o Dolphin Asset Management Corp.
129 East 17th Street
New York, NY  10003
(212) 982-5071

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communication)

August 9, 2002
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(b)(3) or (4), check the following box / /.



*    The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.

The information required on this cover page shall not be deemed to be
"filed" for the purpose of Section 18 of the Securities Exchange Act of 1934
("Act") or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).













1.   NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE
PERSON: Peter E. Salas, as General Partner of Dolphin Offshore Partners, L.P.

2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  ___

3.   SEC USE ONLY

4.   SOURCE OF FUNDS:  WC

5.   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM
     2(d) or 2(e)

6.   CITIZENSHIP OR PLACE OF ORGANIZATION:  USA

7.   SOLE VOTING POWER:  690,365

8.   SHARED VOTING POWER:  0

9.   SOLE DISPOSITIVE POWER:  690,365

10.  SHARED DISPOSITIVE POWER:  0

11.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:  690,365

12.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES: /

13.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):  5.24%

14.  TYPE OF REPORTING PERSON:  IN




























SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

COLORADO MEDTECH, INC.
(Name of Company)

Item 1.   Security and Issuer.

    The title of the class of security to which this statement relates is the
Common Stock of COLORADO MEDTECH, INC., whose principal executive offices are
located at 4801 North 63rd Street, Boulder, Colorado, 80301.


Item 2.   Identity and Background

     This statement is filed by Peter E. Salas, a United States citizen with a
business address at Dolphin Asset Management Corp., 129 East 17th Street, NY,
NY 10003, as General Partner of Dolphin Offshore Partners, L.P. His present
principal occupation is General Partner of Dolphin Offshore Partners, L.P.
During the last five years, Mr. Salas has not been convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors) nor been a
party to a civil proceeding of a judicial or administrative body of competent
jurisdiction subjecting him to a judgment, decree or final order enjoining
future violations of, or prohibiting or mandating activities subject to,
Federal or State securities laws or finding any violation with respect to such
laws.


Item 3.   Source and Amount of Funds or Other Consideration

     690,365 common shares were purchased in the open market between March 5
and August 9, 2002 with the working capital of Dolphin Offshore Partners, L.P.


Item 4.   Purpose of the Transaction

     The common shares were acquired for investment purposes only.


Item 5. Interest in Securities of the Issuer

     Mr. Salas is the beneficial owner of 690,365 common shares.


Item 6.   Contracts, Arrangements, Understandings or
	  Relationships with Respect to Securities of the Issuer

     Mr. Salas has the exclusive right to vote the shares of Common
Stock at any regular or special meetings of the shareholders of the Company
and/or any actions in lieu of meetings or shareholder proceedings.


Item 7.   Material to be Filed as Exhibits


Signatures

     After reasonable inquiry and to the best of his knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct.

Dated: August 15, 2002
 /s/ Peter E. Salas



                                       5